Herduo 250mg Tablet 30s

Introduction to Herduo 250mg Tablet 30s

Herduo 250mg Tablet 30s is a medication primarily used for the treatment of certain types of breast cancer. It is particularly effective in treating HER2-positive breast cancer, which is characterized by the presence of a protein that promotes the growth of cancer cells.

Composition of Herduo 250mg Tablet 30s

The active ingredient in Herduo 250mg Tablet 30s is Lapatinib. Lapatinib works by inhibiting proteins known as tyrosine kinases, which are responsible for the growth and spread of cancer cells.

Uses of Herduo 250mg Tablet 30s

• Treatment of HER2-positive breast cancer
• Slowing the progression of cancer
• Improving survival rates in patients with specific types of breast cancer

Side effects of Herduo 250mg Tablet 30s

• Common side effects: Diarrhea, rash, nausea
• Serious side effects: Liver problems, heart issues

Precautions of Herduo 250mg Tablet 30s

Regular monitoring of liver and heart function is necessary while taking Herduo 250mg Tablet 30s. It is not recommended for individuals with severe liver problems or for use during pregnancy due to potential harm to the unborn baby.

How to Take Herduo 250mg Tablet 30s

The usual starting dose for adults is 1,250 mg taken once daily on an empty stomach, which means at least one hour before or after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of Herduo 250mg Tablet 30s

Herduo 250mg Tablet 30s, containing the active ingredient Lapatinib, is a part of the therapeutic class used to treat HER2-positive breast cancer. It is manufactured to help slow cancer progression and improve survival rates. Regular monitoring and adherence to prescribed usage are crucial for effective treatment. Herduo 250mg Tablet 30s is a significant option for patients with specific breast cancer types, offering targeted therapy with careful consideration of potential side effects.